OCTANT BIO
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure the activity of thousands of receptor pathways in human cells that enable scientists to apply machine learning methods to engineer small molecules that interact with multiple receptors and unlock a new potential to treat complex diseases.
OCTANT BIO
Industry:
Biotechnology Life Science
Founded:
2017-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.octant.bio
Total Employee:
11+
Status:
Active
Total Funding:
115 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Domain Not Resolving Amazon Google Apps For Business JsDelivr
Similar Organizations
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Current Advisors List
Current Employees Featured
Founder
Investors List
What If Ventures
What If Ventures investment in Series B - Octant Bio
Allen & Company
Allen & Company investment in Series B - Octant Bio
Bristol Myers Squibb
Bristol Myers Squibb investment in Series B - Octant Bio
Andreessen Horowitz
Andreessen Horowitz investment in Series B - Octant Bio
Fifty Years
Fifty Years investment in Series B - Octant Bio
Catalio Capital Management
Catalio Capital Management investment in Series B - Octant Bio
Bioverge
Bioverge investment in Series B - Octant Bio
Flucas Ventures
Flucas Ventures investment in Series B - Octant Bio
Andreessen Horowitz
Andreessen Horowitz investment in Series A - Octant Bio
Allen & Company
Allen & Company investment in Series A - Octant Bio
Official Site Inspections
http://www.octant.bio Semrush global rank: 2.15 M Semrush visits lastest month: 9.32 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Octant Bio"
Octant
The Octant platform is enabled, processed, and accelerated by our advanced AI/ML pipelines and tools. Our proprietary chemical biology datasets generate unique insights from millions of data points to advance drug programs. ...See details»
Octant Bio - Crunchbase Company Profile & Funding
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and …See details»
Octant Bio Company Profile 2024: Valuation, Funding …
Octant Bio General Information Description. Developer of synthetic technology designed to improve health and treat disease. The company's platform uses synthetic biology, genome engineering, sequencing, and computational tools …See details»
Octant Bio | World Economic Forum
Octant Bio is a developer of synthetic technology used to improve health and treat disease. Its technology uses synthetic biology, genome engineering, next-generation sequencing, and computational tools to simultaneously measure …See details»
Synthetic biology firm Octant closes $80M funding, …
Apr 21, 2022 Data-driven therapeutics company Octant Bio is exploring new frontiers of drug development with $80 million in-pocket and a freshly signed Big Pharma partnership.. Octant—a historical instrument ...See details»
Octant - Company Profile - Tracxn
Nov 27, 2024 Octant - Provider of human cell interaction platform for drug discovery. Raised a total funding of $115M over 2 rounds from 14 investors. ... Email ID: *****@octant.bio; Key …See details»
Ramsey Homsany - Co-Founder & President @ Octant …
Ramsey Homsany is the founder and president of Octant Bio. Personal Investments. Edit Personal Investments Section. Number of Investments 4. Ramsey Homsany has made 4 investments. Their latest investment was Pre …See details»
Octant Bio - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... May 21, 2020: Series A - Octant Bio . 7: …See details»
Octant Blog: Introducing Octant
Octant is a fundamental bet that recent technological shifts in biology can be mobilized to make step changes in the treatment of complex disease. Since 2007, the price of sequencing DNA has dropped ~100,000-fold. There has been …See details»
The Insanely Fast Wave Of Octant Bio - Ulu Ventures
Jul 17, 2020 Why a hot startup open-sourced their most in-demand technology during COVID19. Octant Bio, an Ulu portfolio company, uses synthetic biology to advance computational drug discovery.They are developing a database of …See details»
Octant Company Profile: , Investments, Contact Information, News ...
Octant is a well-backed team of experienced scientists and entrepreneurs exploring new frontiers of biology. We are applying next-generation DNA sequencing, gene synthesis, and gene …See details»
Octant Bio - Contacts, Employees, Board Members, Advisors
Organization. Octant Bio . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 3. Number of Board …See details»
Octant Raises $80 Million Series B Round to Support Expansion of …
Apr 21, 2022 In addition to Catalio, the Series B financing included participation from Bristol Myers Squibb, and existing investors Andreessen Horowitz Bio Fund, Allen & Co., and 50 …See details»
Technology - octant.bio
The Octant Navigator accelerates design, build, test, learn iterations across chemistry and biology to build drugs against cellular mechanisms. Generative Biology We build mammalian synthetic …See details»
Pharma’s Dirty Secret, And The Synthetic Biology Startup ... - Forbes
Jun 29, 2020 Synthetic biology company Octant Bio has developed a better way to design drugs for the most common and complex diseases like diabetes and heart disease. Octant Bio Many …See details»
BMS joins Octant’s $80M financing and signs on as a drug …
Apr 21, 2022 Octant Bio’s synthetic biology approach to drug discovery is making progress, and the preclinical biotech has raised $80 million in Series B financing to continue the journey.See details»
What Octonauts Are Thankful For - LinkedIn
Nov 24, 2021 And at Octant, we do care about the finer things in life. Like being able to finally get our hair cut after a year of at-home, amateur barber experiences. Leon is especially …See details»
Octant Blog: Scaling Octant’s Approach to Drug Discovery
Apr 21, 2022 We started Octant with the belief that the most significant challenge in drug discovery is deciphering the immense complexity of human disease biology. The convergence …See details»
Our Pipeline - octant.bio
Small molecule correctors are a proven therapeutic approach for such diseases, but have been mostly confined to the small subset of misfolding diseases with a few dominant mutations. The …See details»